{"schema_version":"secwatch.filing_event.v1","accession":"0000917520-26-000055","form_type":"8-K","ticker":"IART","cik":"0000917520","company_name":"INTEGRA LIFESCIENCES HOLDINGS CORP","filed_at":"2026-07-29T10:15:13+00:00","discovered_at":"2026-07-29T10:20:00.305850+00:00","generated_at":"2026-07-29T10:20:11.586655+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Integra Q2 2026: Revenue $418.8M (+0.8%), Adj EPS $0.56 vs $0.45; reaffirms FY adj EPS $2.40-$2.50","bullets":["Q2 revenue $418.8M (+0.8% reported, +0.7% organic); GAAP EPS $0.06 vs -$6.31; adjusted EPS $0.56 vs $0.45.","Adjusted EBITDA $78.4M (18.7% of revenue) vs $71.2M (17.1%) in prior year.","Specialty Surgery revenue $309.3M (+1.6% organic); Tissue Reconstruction $109.5M (-2.0% organic).","Full-year reported revenue guidance narrowed to $1.654B-$1.695B (from $1.662B-$1.702B) due to FX; organic growth and adj EPS reaffirmed.","Braintree facility producing; SurgiMend relaunch on track for Q4 2026."],"urls":{"canonical":"https://secwatch.observer/filing/0000917520-26-000055","json":"https://secwatch.observer/filing/0000917520-26-000055.json","markdown":"https://secwatch.observer/filing/0000917520-26-000055.md","text":"https://secwatch.observer/filing/0000917520-26-000055.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/917520/000091752026000055/0000917520-26-000055-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/917520/000091752026000055/iart-20260729.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-07-29T10:20:11.586655+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}